Inventor · disambiguated record
Lawrence Blas Perez
Also filed as: PEREZ LAWRENCE B · PEREZ LAWRENCE BLAS
23 granted patents·11 pending applications·506 citations·filing 2001–2023
95Inventor score
Files withNOVARTIS AG16BRAIN CHRISTOPHER THOMAS3CHEN CHRISTINE HIU-TUNG3CARAVATTI GIORGIO2CASTRO ALFREDO C2
Top patents by PatentIndex Score
34 records- 0197US6552065B2Deacetylase inhibitorsNOVARTIS AG·Filed 2001·Granted Apr 22, 2003·338 cites·27 claims
- 0292US10968235B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2019·Granted Apr 6, 2021·3 cites·3 claims
- 0392US10934285B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2017·Granted Mar 2, 2021·5 cites·5 claims
- 0492US10077276B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2015·Granted Sep 18, 2018·15 cites·22 claims
- 0591US7067551B2Deacetylase inhibitorsNOVARTIS AG·Filed 2004·Granted Jun 27, 2006·36 cites·9 claims
- 0691US6833384B2Deacetylase inhibitorsNOVARTIS AG·Filed 2002·Granted Dec 21, 2004·32 cites·8 claims
- 0790US10336774B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2018·Granted Jul 2, 2019·7 cites·22 claims
- 0890US10093646B21-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2015·Granted Oct 9, 2018·7 cites·10 claims
- 0990US9815813B21-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2CHEN ZHUOLIANG·Filed 2015·Granted Nov 14, 2017·13 cites·8 claims
- 1088US10301278B21-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2NOVARTIS AG·Filed 2017·Granted May 28, 2019·8 cites·7 claims
- 1188US9309252B2Pyrrolopyrimidine compounds as inhibitors of CDK4/6BRAIN CHRISTOPHER THOMAS·Filed 2014·Granted Apr 12, 2016·12 cites·18 claims
- 1286US10287266B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2016·Granted May 14, 2019·8 cites·13 claims
- 1385US8957074B2Pyrrolopyrimidine compounds as inhibitors of CDK4/6BRAIN CHRISTOPHER THOMAS·Filed 2011·Granted Feb 17, 2015·9 cites·40 claims
- 1479US2024199609A1Compounds and compositions for inhibiting the activity of shp2NOVARTIS AG·Filed 2023·Application pending·0 cites
- 1577US2022073537A1N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1675US11952386B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2021·Granted Apr 9, 2024·0 cites·12 claims
- 1775US2022348553A11-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of shp2NOVARTIS AG·Filed 2022·Application pending·0 cites
- 1874US12209098B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2021·Granted Jan 28, 2025·0 cites·26 claims
- 1974US7169817B2Bis-aromatic alkanolsIRM LLC·Filed 2003·Granted Jan 30, 2007·12 cites·7 claims
- 2070US11905283B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2020·Granted Feb 20, 2024·0 cites·8 claims
- 2169US11401259B21-Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2NOVARTIS AG·Filed 2020·Granted Aug 2, 2022·0 cites·4 claims
- 2264US10774065B21-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2018·Granted Sep 15, 2020·0 cites·3 claims
- 2363US8598217B2Imidazole derivatives and their use as modulators of cyclin dependent kinasesHOWARD STEVEN·Filed 2010·Granted Dec 3, 2013·1 cites·18 claims
- 2463US2008176849A1Deacetylase inhibitorsREMISZEWSKI STACY WILLIAM·Filed 2008·Application pending·0 cites
- 2559US7928244B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY DISCOVERY INC·Filed 2007·Granted Apr 19, 2011·0 cites·37 claims
- 2658US2006189674A1Deacetylase inhibitorsREMISZEWSKI STACY W·Filed 2006·Application pending·0 cites
- 2756US8178690B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2011·Granted May 15, 2012·0 cites·15 claims
- 2854US8609706B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2012·Granted Dec 17, 2013·0 cites·14 claims
- 2951US2008096883A1Trifluoromethyl substituted benzamides as kinase inhibitorsCARAVATTI GIORGIO·Filed 2005·Application pending·0 cites
- 3051US2006035897A1Trifluoromethyl substituted benzamides as kinase inhibitorsCARAVATTI GIORGIO·Filed 2005·Application pending·0 cites
- 3147US2010048539A1Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2007·Application pending·0 cites
- 3245US2007060582A11,4-Disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseasesFINK CYNTHIA A·Filed 2004·Application pending·0 cites
- 3343US2009306107A1Organic CompoundsNOVARTIS AG·Filed 2006·Application pending·0 cites
- 3437US2013203765A1Deuterated pyrrolopyrimidine compounds as inhibitors of cdk4/6BRAIN CHRISTOPHER THOMAS·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →